Ageing, neurodegeneration and Parkinson's disease
2010/01/05 by J. V. Hindle, John V. Hindle · 29 citations
Medicine · Neuroscience · #Parkinson's Disease Mechanisms and Treatments #Nuclear Receptors and Signaling #Neurological disorders and treatments
paper · pdf · doi:10.1093/ageing/afp223
Abstract
Age is the largest risk factor for the development and progression of Parkinson's disease (PD). Ageing affects many cellular processes that predispose to neurodegeneration, and age-related changes in cellular function predispose to the pathogenesis of PD. The accumulation of age-related somatic damage combined with a failure of compensatory mechanisms may lead to an acceleration of PD with age. The formation of Lewy bodies may represent a marker for protective mechanisms against age-related dysfunction and degeneration of the nervous system. Mild parkinsonian signs may be present in older people, which are associated with reduced function. These may be due to age-related decline in dopaminergic activity, incidental Lewy body disease, degenerative pathologies (early PD and Alzheimer's disease) or vascular pathology. Ageing may affect the clinical presentation of PD with altered drug side effects, increased risk of developing dementia and an increased likelihood of admission to a nursing home. Progression of PD, including the development of dementia, and hallucinations is related to the age of the patient rather than the age of disease onset. PD may reflect a failure of the normal cellular compensatory mechanisms in vulnerable brain regions, and this vulnerability is increased by ageing. PD is one of the best examples of an age-related disease.
Cited by
- Retinal nerve fibre layer thickness measured with SD-OCT in a population-based study: the Handan Eye Study
- Global, regional and national burden of Parkinson's disease, 1990–2021: Update from the GBD 2021 study
- Advanced brain aging, selective vulnerability in gray matter, and cognition in Parkinson’s disease
- Integrating polygenic signals and single-cell multiomics identifies cell-type-specific regulomes critical for immune- and aging-related diseases
- Insulin resistance impairs nigrostriatal dopamine function. [europepmc]
- Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease. [europepmc]
- Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). [europepmc]
- Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. [europepmc]
- Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. [europepmc]
- Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation. [europepmc]
- RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. [europepmc]
- At the interface of sensory and motor dysfunctions and Alzheimer's disease. [europepmc]
- The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. [europepmc]
- Endocytic membrane trafficking and neurodegenerative disease. [europepmc]
- Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles. [europepmc]
- Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database. [europepmc]
- Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain. [europepmc]
- The Role of Immunosenescence in Neurodegenerative Diseases. [europepmc]
- Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. [europepmc]
- Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease? [europepmc]
- The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System. [europepmc]
- Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. [europepmc]
- Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair. [europepmc]
- Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance. [europepmc]
- The Free-movement pattern Y-maze: A cross-species measure of working memory and executive function. [europepmc]
- Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review. [europepmc]
- Region-specific vulnerability in neurodegeneration: lessons from normal ageing. [europepmc]
- The Contribution of Microglia to Neuroinflammation in Parkinson's Disease. [europepmc]
- The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain. [europepmc]
Related